+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pneumococcal Vaccines Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803402
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • Bayer AG
  • Biomed Pvt. Ltd.
  • CSL Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Nuron Biotech Inc.
  • MORE
The report on the global pneumococcal vaccines market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global pneumococcal vaccines market to grow with a CAGR of 3.3% over the forecast period from 2019-2025. The study on pneumococcal vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on pneumococcal vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pneumococcal vaccines market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pneumococcal vaccines market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Increasing number of people suffering from pneumococcal disease
  • Rising availability of pneumococcal vaccination
  • Huge investments and partnerships by the pharmaceutical companies
2) Restraints
  • High costs required in the manufacturing of pneumococcal vaccines
3) Opportunities
  • Research and development
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global pneumococcal vaccines market is segmented on the basis of product type, and distribution channel.

The Global Pneumococcal Vaccines Market by Product Type
  • Pneumococcal conjugate vaccine
  • Pneumococcal polysaccharide vaccine
The Global Pneumococcal Vaccines Market by Distribution Channel
  • Clinics
  • Hospitals
  • Non-governmental organizations
  • Government authorities
Company Profiles
The companies covered in the report include
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Nuron Biotech Inc.
  • CSL Ltd.
  • Biomed Pvt. Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Sanofi Pasteur Inc.
  • JN-International Medical Corporation
  • Merck & Co., Inc.
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the pneumococcal vaccines market.
2. Complete coverage of all the segments in the pneumococcal vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global pneumococcal vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Biomed Pvt. Ltd.
  • CSL Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Nuron Biotech Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Pneumococcal Vaccines Market Highlights
2.2. Pneumococcal Vaccines Market Projection
2.3. Pneumococcal Vaccines Market Regional Highlights

3. Global Pneumococcal Vaccines Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product Type
3.4.2. Growth Matrix Analysis by Distribution Channel
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Pneumococcal Vaccines Market

4. Pneumococcal Vaccines Market Macro Indicator Analysis

5. Global Pneumococcal Vaccines Market by Product Type
5.1. Pneumococcal Conjugate Vaccine
5.2. Pneumococcal Polysaccharide Vaccine

6. Global Pneumococcal Vaccines Market by Distribution Channel
6.1. Clinics
6.2. Hospitals
6.3. Non-governmental Organizations
6.4. Government Authorities

7. Global Pneumococcal Vaccines Market by Region 2019-2025
7.1. North America
7.1.1. North America Pneumococcal Vaccines Market by Product Type
7.1.2. North America Pneumococcal Vaccines Market by Distribution Channel
7.1.3. North America Pneumococcal Vaccines Market by Country
7.2. Europe
7.2.1. Europe Pneumococcal Vaccines Market by Product Type
7.2.2. Europe Pneumococcal Vaccines Market by Distribution Channel
7.2.3. Europe Pneumococcal Vaccines Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Pneumococcal Vaccines Market by Product Type
7.3.2. Asia-Pacific Pneumococcal Vaccines Market by Distribution Channel
7.3.3. Asia-Pacific Pneumococcal Vaccines Market by Country
7.4. RoW
7.4.1. RoW Pneumococcal Vaccines Market by Product Type
7.4.2. RoW Pneumococcal Vaccines Market by Distribution Channel
7.4.3. RoW Pneumococcal Vaccines Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Pneumococcal Vaccines Market
8.2. Companies Profiles
8.2.1. Bayer AG
8.2.2. GlaxoSmithKline plc
8.2.3. Pfizer Inc.
8.2.4. Nuron Biotech Inc.
8.2.5. CSL Ltd.
8.2.6. Biomed Pvt. Ltd.
8.2.7. Serum Institute of India Pvt. Ltd.
8.2.8. Sanofi Pasteur Inc.
8.2.9. JN-International Medical Corporation
8.2.10. Merck & Co., Inc.

9. Appendix
9.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Nuron Biotech Inc.
  • CSL Ltd.
  • Biomed Pvt. Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Sanofi Pasteur Inc.
  • JN-International Medical Corporation
  • Merck & Co., Inc.
Note: Product cover images may vary from those shown
Adroll
adroll